bucks- no reason, just sell
it's just a presentation of scientific primary endpoint data of combo pivotal trial, sort of like a clock at 5 to 12 before the big gong. It is nothing.
Then the millions of shares diluting the value from $11.39/sh down to $8.50'ish per share is just horrible.
Company should just sack and pack right before the finishing line, because we shareholder have waited a few years.
Next time we shall just invest in MoviePass alike deals which has a much shorter time to bankruptcy than the average 9 years in biotech.
/sarcasm can be kept if found (o8>